Amisulpride

It's just a different risk profile, and for chronic use, the trade is usually worth it.

What about Amisulpride? Amisulpride is a selective D2 and D3 antagonist, and it's been approved for intravenous use in post-operative nausea and vomiting.

A 2026 randomized trial in neurosurgery patients found intravenous amisulpride at 5 mg was non-inferior to ondansetron at 4 mg for preventing post-operative nausea and vomiting.

Non-inferior to ondansetron is a real result.

Once I explained all this kind of nasty thoughts on etol, okay, better.

Let's add up some anti-psychotic called Amisulfride, which is Solian,

I

can say, or a different kind of brand in the US.